AJO LP’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-106,444
| Closed | -$30.2M | – | 316 |
|
|
2020
Q3 | $30.2M | Sell |
106,444
-316,654
| -75% | -$88.3M | 0.32% | 88 |
|
|
2020
Q2 | $113M | Buy |
423,098
+340,674
| +413% | +$102M | 1.03% | 30 |
|
|
2020
Q1 | $26.1M | Buy |
82,424
+48,181
| +141% | +$14.6M | 0.23% | 117 |
|
|
2019
Q4 | $10.2M | Buy |
34,243
+21,397
| +167% | +$5.94M | 0.06% | 215 |
|
|
2019
Q3 | $2.99M | Buy |
+12,846
| New | +$2.99M | 0.02% | 355 |
|
|
2019
Q2 | – | Sell |
-8,817
| Closed | -$2.08M | – | 630 |
|
|
2019
Q1 | $2.08M | Buy |
8,817
+3
| +0% | +$945 | 0.01% | 450 |
|
|
2018
Q4 | $2.65M | Sell |
8,814
-18,813
| -68% | -$6M | 0.01% | 411 |
|
|
2018
Q3 | $9.76M | Sell |
27,627
-69,198
| -71% | -$23.8M | 0.05% | 246 |
|
|
2018
Q2 | $28.1M | Sell |
96,825
-173,226
| -64% | -$48.7M | 0.13% | 162 |
|
|
2018
Q1 | $73.9M | Buy |
270,051
+167,785
| +164% | +$52.1M | 0.34% | 93 |
|
|
2017
Q4 | $32.6M | Sell |
102,266
-13,298
| -12% | -$4.27M | 0.14% | 154 |
|
|
2017
Q3 | $36.2M | Sell |
115,564
-128,605
| -53% | -$38.1M | 0.16% | 152 |
|
|
2017
Q2 | $66.3M | Sell |
244,169
-25,300
| -9% | -$6.69M | 0.28% | 102 |
|
|
2017
Q1 | $73.7M | Buy |
269,469
+11,526
| +4% | +$3.26M | 0.3% | 90 |
|
|
2016
Q4 | $73.1M | Buy |
257,943
+9,090
| +4% | +$2.69M | 0.3% | 94 |
|
|
2016
Q3 | $77.9M | Buy |
248,853
+108,522
| +77% | +$32.1M | 0.33% | 88 |
|
|
2016
Q2 | $33.9M | Buy |
140,331
+99,758
| +246% | +$26.3M | 0.15% | 127 |
|
|
2016
Q1 | $10.6M | Buy |
40,573
+14,201
| +54% | +$3.75M | 0.05% | 225 |
|
|
2015
Q4 | $8.08M | Sell |
26,372
-2,242
| -8% | -$644K | 0.04% | 250 |
|
|
2015
Q3 | $8.35M | Sell |
28,614
-43,986
| -61% | -$14.5M | 0.04% | 253 |
|
|
2015
Q2 | $29.3M | Sell |
72,600
-518,110
| -88% | -$208M | 0.13% | 133 |
|
|
2015
Q1 | $249M | Sell |
590,710
-86,430
| -13% | -$34.1M | 1.04% | 25 |
|
|
2014
Q4 | $230M | Sell |
677,140
-49,900
| -7% | -$16.1M | 0.97% | 36 |
|
|
2014
Q3 | $241M | Sell |
727,040
-21,310
| -3% | -$7.03M | 1.07% | 29 |
|
|
2014
Q2 | $236M | Sell |
748,350
-11,670
| -2% | -$3.51M | 1.01% | 36 |
|
|
2014
Q1 | $232M | Sell |
760,020
-41,700
| -5% | -$13.2M | 1.01% | 43 |
|
|
2013
Q4 | $224M | Sell |
801,720
-186,140
| -19% | -$48.1M | 0.98% | 44 |
|
|
2013
Q3 | $238M | Buy |
987,860
+185,460
| +23% | +$41.5M | 1.08% | 33 |
|
|
2013
Q2 | $173M | Buy |
+802,400
| New | +$171M | 0.8% | 46 |
|
Other funds holding BIIB
AJO LP's BIIB Position: Q4 2020 in Review
AJO LP sold out of Biogen (BIIB) in Q4 2020, closing a stake of 106,444 shares — an estimated $30.2M sold.
AJO LP first reported a position in BIIB in Q2 2013 and held it in 29 quarters. The position peaked at $249M in Q1 2015. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.
- AJO LP reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
- AJO LP sold 106,444 Biogen shares in Q4 2020, an estimated $30.2M.
- AJO LP first reported a position in Biogen in Q2 2013 and held it in 29 quarters.
- AJO LP's Biogen position peaked at $249M in Q1 2015.
- 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.
Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.